Developer docs
API playgroundTry for free, no card

Search company profiles

Infervision

Full company profile

uuid0000dx9

Namestring
Infervision
Legal namestring
Infervision
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Infervision is a Beijing-headquartered AI medical imaging company founded in 2015/2016 that develops deep learning and computer vision software to assist in disease screening, diagnosis, surgical planning, and patient management across CT, X-ray, MRI, and ultrasound modalities. Its portfolio is organized into four software families: InferRead (diagnostic detection covering lung nodules, stroke, pneumonia, coronary stenosis, and bone fractures), InferOperate (3D reconstruction for thoracic, liver, and urology surgical planning, including a unified FDA-cleared Suite), InferCare (longitudinal patient management including the RECIST tumor response platform), and InferScholar/InferMatrix (research and application platforms), plus InferAir, a 25 kg ultra-portable X-ray device for offline TB screening. The company monetizes through B2B enterprise licensing of its AI software to hospitals and imaging centers on a quote-based demo sales motion, with no publicly disclosed pricing, and supplements direct sales with channel partnerships through Microsoft (Precision Imaging Network / Nuance), NVIDIA (MONAI framework and TensorRT inference), SimonMed in the US, and UN agencies (UNDP, Global Fund, UNOPS) for government health programs. Infervision holds regulatory clearances across all five major markets — FDA, CE, UKCA, PMDA, and NMPA (including multiple Class III NMPA registrations) — operates offices in China, Germany, the UK, and the US, and reports active deployment across 30+ countries with 380+ filed patents and 330+ peer-reviewed publications.

Short descriptiontext

Infervision is a Beijing-based AI medical imaging company that develops deep learning software for disease screening, diagnosis, surgical planning, and oncology management, serving hospitals, imaging centers, and government health programs across 30+ countries with regulatory clearances in the US, Europe, UK, Japan, and China.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersLyndhurst, United States
HQ citystring
Lyndhurst
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
AI medical imaging, diagnostic imaging software, surgical planning software, oncology AI, tuberculosis screening
Industry7 codes
PRIMARYHLAHABAJ
Radiology AI, CAD & Advanced Visualization Software
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHDAAAEAH
Medical Imaging AI
SECONDARYHLACABAM
Imaging & Diagnostic Interoperability (DICOM exchange, image sharing, VNA connectivity)
Healthcare & Life Sciences/Digital Health & Health IT/Health Information Exchange (HIE) & Interoperability
SECONDARYHLACALAG
AI Orchestration & Imaging Analytics Platforms (Model Management/Triage)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLAHADAH
Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLACALAD
Universal Viewers & Enterprise Imaging Access (Zero-footprint/Diagnostic)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLAHABAI
Imaging Informatics & Workflow (PACS/RIS/VNA)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
NAICS code3 codes
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing33451
  • Software Publishers513210
  • Surgical and Medical Instrument Manufacturing339112
SIC code3 codes
  • Surgical & Medical Instruments & Apparatus3841
  • X-Ray Apparatus & Tubes & Related Irradiation Apparatus3844
  • Laboratory Analytical Instruments3826
Product category
AI Medical Imaging Software
Social media profiles1 record
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model1 record
1AI Medical Imaging Software Licenses
TypeSubscription Recurring
Description

Infervision generates revenue through licensing its AI medical imaging software products including InferRead (diagnosis), InferOperate (surgical planning), InferCare (patient management), and InferScholar (research platform). The company operates across multiple regulatory markets (FDA, CE, UKCA, PMDA, NMPA) enabling global software deployment. Revenue is primarily B2B, sold to hospitals and healthcare institutions.

global.infervision.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 6 records shown
1InferRead
Description

AI-assisted disease screening and diagnosis product line including CT Lung, DR Chest, CT Coronary, CT Stroke, CT Bone, and CT Pneumonia solutions

global.infervision.com
+5 more records
Core offering1 text field

Infervision develops and sells AI-powered medical imaging software that applies deep learning and computer vision to support screening, diagnosis, surgical planning, and patient management across CT, X-ray, MRI, and ultrasound modalities. The portfolio spans lung and chest screening, stroke triage, coronary analysis, bone age assessment, pneumonia detection, and a dedicated line of surgical planning and post-treatment follow-up tools sold primarily to hospitals, radiology departments, and public health programs.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • 93.1% station-specific sensitivity for detecting cancerous lymph nodes in chest CT scans
+6 more records
Product overview1 text field

Infervision is an AI medical technology company offering a comprehensive portfolio of medical imaging AI solutions organized into three main product lines: InferRead (disease screening and diagnosis), InferOperate (surgical planning), and InferCare/InferScholar (patient management and research). InferRead products provide AI-powered analysis across multiple imaging modalities including CT scans and X-rays, covering lung cancer screening, stroke detection, bone fractures, pneumonia, and coronary artery assessment. InferOperate Suite delivers automated 3D reconstruction for preoperative surgical planning across thoracic, liver, and urology procedures. The ecosystem is supported by InferCare for patient management and longitudinal tracking, InferScholar for research applications, and InferMatrix for AI model deployment. InferAir extends the portfolio with an ultra-portable X-ray device for remote TB screening.

Product and service15 records
1InferRead CT Lung
CategoryAI Diagnostic Imaging - Chest/Lung
Description

AI-powered lung CT analysis solution for lung cancer screening and pulmonary nodule detection, designed for hospitals, radiology departments, and large-scale lung cancer screening programs.

2InferRead DR Chest
CategoryAI Diagnostic Imaging - Chest/X-Ray
Description

AI-assisted digital chest X-ray interpretation software that detects and classifies thoracic abnormalities, including tuberculosis, targeting hospitals, TB screening programs, and government public-health initiatives.

3InferRead CT Stroke
CategoryAI Diagnostic Imaging - Neurology
Description

AI triage software that analyzes non-contrast head CT scans to flag suspected intracerebral hemorrhage and large vessel occlusion, supporting emergency radiology and stroke centers in time-critical decisions.

4InferRead CT Coronary
CategoryAI Diagnostic Imaging - Cardiology
Description

AI software for coronary CT angiography that performs automatic coronary artery segmentation, plaque characterization, and stenosis assessment, intended for cardiology departments and advanced imaging centers.

5InferRead CT Bone
CategoryAI Diagnostic Imaging - Orthopedics
Description

AI bone analysis software that automates bone age assessment and supports orthopedic CT interpretation for hospitals, pediatric imaging, and orthopedic departments.

6InferRead CT Pneumonia
CategoryAI Diagnostic Imaging - Infectious Disease
Description

AI software that detects, segments, and quantifies pneumonia-related opacities on chest CT, designed to support radiology departments during high-volume infectious disease surges such as COVID-19.

7InferOperate Thorax Planning
CategoryAI Surgical Planning - Thoracic
Description

AI surgical planning software that performs automatic lung lesion segmentation and 3D anatomical reconstruction to support thoracic surgeons in pre-operative planning.

8InferOperate Liver Planning
CategoryAI Surgical Planning - Hepatobiliary
Description

AI software for liver surgical planning that provides automatic liver and lesion segmentation, vascular reconstruction, and volumetric analysis for hepatobiliary surgeons.

9InferOperate Urology Planning
CategoryAI Surgical Planning - Urology
Description

AI surgical planning software that performs automatic kidney and prostate segmentation with 3D reconstruction, supporting urologists in pre-operative planning.

10InferOperate Suite
CategoryAI Surgical Planning Platform
Description

Unified surgical planning platform that consolidates InferOperate thoracic, liver, and urology planning modules into a single clinical workflow environment for surgical departments.

11InferCare
CategoryAI Patient Management Software
Description

AI-enabled patient management software that organizes imaging findings, longitudinal records, and follow-up workflows for oncology and chronic disease management in hospital settings.

12InferCare RECIST
CategoryAI Oncology Follow-up Software
Description

FDA-cleared AI software that performs automated tumor response assessment according to RECIST 1.1 criteria, supporting oncologists and radiology teams in follow-up imaging workflows.

13InferScholar
CategoryAI Research Platform
Description

Medical imaging AI research platform that enables hospitals and research institutions to develop, validate, and operationalize custom deep learning models for clinical research projects.

14InferMatrix
CategoryAI Application Platform
Description

Integrated AI application platform that hosts and orchestrates multiple Infervision imaging AI modules within a unified clinical workflow interface for hospitals and imaging centers.

15InferAir
CategoryAI-Enabled Portable X-Ray Hardware
Description

Portable digital X-ray device with embedded AI for chest and tuberculosis screening, designed for mobile clinics, remote health programs, and resource-limited healthcare settings.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership12 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-11-30
Description

InferVision's AI models have been integrated into the Microsoft Precision Imaging Network (Microsoft + Nuance). Through cloud deployment via Azure, this partnership enables accelerated, standardized, and widely accessible intelligent imaging workflows for healthcare institutions worldwide. The integration leverages Microsoft's healthcare customer base and cloud infrastructure.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-11-30
Description

InferVision leverages NVIDIA's advanced MONAI framework and TensorRT-accelerated inference to enhance AI development across screening, diagnosis, surgical planning, and oncology analysis. The MONAI framework has improved InferVision's R&D efficiency, while NVIDIA's DLI training supports advancement of large-model technologies.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Research collaboration with Sanford Health (largest rural nonprofit healthcare system in the US with 56 hospitals and nearly 300 clinics) for AI-powered cancer detection. Sanford Health researchers used Infervision's AI system combining RetinaNet detection algorithm with UNet segmentation model for detecting cancerous lymph nodes in chest CT scans, achieving 93.1% station-specific sensitivity.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Partnership with SimonMed, one of the largest outpatient medical imaging providers in the US. Established in 2023, this partnership enables Infervision to access a large network of imaging centers for deployment of AI diagnostic solutions.

5United Nations Development Programme (UNDP)
Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

Partnership with UNDP for TB screening programs in developing countries. UNDP and governments work together to deploy Infervision's AI solutions for tuberculosis screening in countries like Kyrgyzstan and Zimbabwe.

global.infervision.com
Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

Partnership with Global Fund for deployment of AI-powered TB screening in resource-limited settings. The Global Fund supports health programs in developing countries and has partnered with Infervision to deploy InferAir technology.

Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Medical mission partnership with Harvard University for deploying InferAir (AI-powered ultra-portable X-ray) in remote Philippines islands. Harvard researchers collaborated with Partners in Health and Infervision for healthcare delivery to underserved populations.

Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Partnership with Partners in Health for medical missions deploying AI-powered healthcare solutions in remote areas. Combined effort with Harvard University and Infervision for remote island healthcare delivery.

9University Hospital Frankfurt
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Clinical collaboration with University Hospital Frankfurt where Dr. Sayzana Kassahun uses InferOperate Thorax for thoracic surgery planning. The hospital serves as a reference site and provides clinical feedback for product development.

global.infervision.com
10Hôpital Tenon (Tenon University Hospital Paris)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Clinical collaboration with Hôpital Tenon in Paris where Dr. Harry Etienne uses InferOperate Thorax for minimally invasive thoracic surgery. The hospital serves as a reference site for surgical planning AI.

global.infervision.com
Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

Infervision product selected into NHS procurement list in 2022, enabling deployment across UK National Health Service hospitals and healthcare facilities.

Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

Product procured by the European Commission and included in medical devices ordering list under Global Drug Facility (GDF) hosted by United Nations Office for Project Services (UNOPS) in 2020. Enables deployment in European and international health programs.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

DeepHealth, a RadNet subsidiary, provides AI-powered diagnostic and screening radiology solutions including lung, breast, and prostate imaging. It competes with Infervision's InferRead product line and benefits from RadNet's large outpatient imaging footprint, similar to Infervision's SimonMed partnership.

TypeDirect peer
Description

Qure.ai develops deep learning algorithms for chest X-ray, CT lung nodule detection, head CT triage, and tuberculosis screening — closely matching Infervision's product portfolio. It is a direct competitor in both hospital radiology and government TB screening programs in emerging markets.

3Nanox (Zebra Medical Vision)
TypeEmerging player
Description

Nanox acquired Zebra Medical Vision, an AI medical imaging company with broad population-health imaging algorithms across CT and X-ray. It overlaps with Infervision's screening and diagnosis portfolio and competes in value-based care AI deployment models.

TypeBroad incumbent
Description

Philips is a global medical imaging incumbent with IntelliSpace AI, an imaging informatics platform offering Algorithm Marketplace integration with third-party AI including radiology AI. As a broad incumbent, it competes with Infervision by offering embedded AI within its installed PACS/imaging base.

TypeDirect peer
Description

Lunit is a Korea-based medical AI company with FDA-cleared chest X-ray and mammography AI products (Lunit INSIGHT). It competes with InferRead DR Chest and similar lung cancer screening use cases and has overlapping hospital and screening program customers.

TypeBroad incumbent
Description

Siemens Healthineers offers AI-Rad Companion, a radiology AI suite integrated into its imaging modalities and teamplay platform. As a major imaging equipment OEM, it competes with Infervision's InferRead and InferOperate by bundling AI into installed scanner bases.

TypeDirect peer
Description

Viz.ai specializes in AI-powered stroke and cardiology triage, with FDA-cleared algorithms for large vessel occlusion detection and care coordination. It directly overlaps with Infervision's InferRead CT Stroke and CT Coronary products and competes for similar hospital radiology and neurovascular contracts.

8United Imaging Intelligence
TypeRegional player
Description

United Imaging Intelligence is the AI subsidiary of United Imaging Healthcare, a major Chinese medical imaging equipment manufacturer. It offers AI-powered imaging analytics for CT, MR, and X-ray, serving similar hospital customers in China and competing with Infervision's domestic Chinese business.

TypeDirect peer
Description

Aidoc is a leading AI medical imaging company offering deep learning algorithms for triage and detection across CT and X-ray modalities (e.g., stroke, pulmonary embolism, intracranial hemorrhage). It competes directly with Infervision's InferRead suite in hospital AI workflows and shares similar enterprise sales motion and regulatory clearance strategy.

TypeDirect peer
Description

Annalise.ai provides comprehensive AI analysis across chest X-ray and CT, including 130+ findings detection. It competes directly with InferRead DR Chest and CT Lung in multi-finding chest imaging workflows and targets similar hospital radiology customers.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers12 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature13 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors16 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Infervision

AI Medical Imaging Softwareglobal.infervision.com

Infervision is a Beijing-based AI medical imaging company that develops deep learning software for disease screening, diagnosis, surgical planning, and oncology management, serving hospitals, imaging centers, and government health programs across 30+ countries with regulatory clearances in the US, Europe, UK, Japan, and China.

What Infervision does

Infervision is a Beijing-headquartered AI medical imaging company founded in 2015/2016 that develops deep learning and computer vision software to assist in disease screening, diagnosis, surgical planning, and patient management across CT, X-ray, MRI, and ultrasound modalities. Its portfolio is organized into four software families: InferRead (diagnostic detection covering lung nodules, stroke, pneumonia, coronary stenosis, and bone fractures), InferOperate (3D reconstruction for thoracic, liver, and urology surgical planning, including a unified FDA-cleared Suite), InferCare (longitudinal patient management including the RECIST tumor response platform), and InferScholar/InferMatrix (research and application platforms), plus InferAir, a 25 kg ultra-portable X-ray device for offline TB screening. The company monetizes through B2B enterprise licensing of its AI software to hospitals and imaging centers on a quote-based demo sales motion, with no publicly disclosed pricing, and supplements direct sales with channel partnerships through Microsoft (Precision Imaging Network / Nuance), NVIDIA (MONAI framework and TensorRT inference), SimonMed in the US, and UN agencies (UNDP, Global Fund, UNOPS) for government health programs. Infervision holds regulatory clearances across all five major markets — FDA, CE, UKCA, PMDA, and NMPA (including multiple Class III NMPA registrations) — operates offices in China, Germany, the UK, and the US, and reports active deployment across 30+ countries with 380+ filed patents and 330+ peer-reviewed publications.

Infervision firmographics

Firmographics
Name
Infervision
Legal name
Infervision
Website
https://global.infervision.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
51–100 employees
Short description
Infervision is a Beijing-based AI medical imaging company that develops deep learning software for disease screening, diagnosis, surgical planning, and oncology management, serving hospitals, imaging centers, and government health programs across 30+ countries with regulatory clearances in the US, Europe, UK, Japan, and China.
Ownership category
akta.pro rank

Infervision industry classification

Industry
Product category
AI Medical Imaging Software
NAICS
Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451), Software Publishers (513210), Surgical and Medical Instrument Manufacturing (339112)
SIC
Surgical & Medical Instruments & Apparatus (3841), X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844), Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHLAHABAJ
Radiology AI, CAD & Advanced Visualization Software
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHDAAAEAH
Medical Imaging AI
SECONDARYHLACABAM
Imaging & Diagnostic Interoperability (DICOM exchange, image sharing, VNA connectivity)
Healthcare & Life Sciences/Digital Health & Health IT/Health Information Exchange (HIE) & Interoperability
SECONDARYHLACALAG
AI Orchestration & Imaging Analytics Platforms (Model Management/Triage)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLAHADAH
Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLACALAD
Universal Viewers & Enterprise Imaging Access (Zero-footprint/Diagnostic)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLAHABAI
Imaging Informatics & Workflow (PACS/RIS/VNA)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment

Keywords

  • AI medical imaging
  • Diagnostic imaging software
  • Surgical planning software
  • Oncology AI
  • Tuberculosis screening

Where Infervision is headquartered

Location

Headquarters

HQ city
Lyndhurst
HQ country
United States
HQ region
North America

Offices5 records

Markets served

Infervision business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. AI Medical Imaging Software Licenses: Infervision generates revenue through licensing its AI medical imaging software products including InferRead (diagnosis), InferOperate (surgical planning), InferCare (patient management), and InferScholar (research platform). The company operates across multiple regulatory markets (FDA, CE, UKCA, PMDA, NMPA) enabling global software deployment. Revenue is primarily B2B, sold to hospitals and healthcare institutions.

Go-to-market motion3 records

Distribution channels5 records

Marketing channels8 records

Infervision product offering

Product offering

Core offering

Infervision develops and sells AI-powered medical imaging software that applies deep learning and computer vision to support screening, diagnosis, surgical planning, and patient management across CT, X-ray, MRI, and ultrasound modalities. The portfolio spans lung and chest screening, stroke triage, coronary analysis, bone age assessment, pneumonia detection, and a dedicated line of surgical planning and post-treatment follow-up tools sold primarily to hospitals, radiology departments, and public health programs.

Product overview

Infervision is an AI medical technology company offering a comprehensive portfolio of medical imaging AI solutions organized into three main product lines: InferRead (disease screening and diagnosis), InferOperate (surgical planning), and InferCare/InferScholar (patient management and research). InferRead products provide AI-powered analysis across multiple imaging modalities including CT scans and X-rays, covering lung cancer screening, stroke detection, bone fractures, pneumonia, and coronary artery assessment. InferOperate Suite delivers automated 3D reconstruction for preoperative surgical planning across thoracic, liver, and urology procedures. The ecosystem is supported by InferCare for patient management and longitudinal tracking, InferScholar for research applications, and InferMatrix for AI model deployment. InferAir extends the portfolio with an ultra-portable X-ray device for remote TB screening.

Differentiator

Problem solved

Functional benefit

Brands

  • InferRead: AI-assisted disease screening and diagnosis product line including CT Lung, DR Chest, CT Coronary, CT Stroke, CT Bone, and CT Pneumonia solutions
  • InferOperate
  • InferCare
  • InferScholar
  • InferMatrix
  • InferAir

Products and services

  • InferRead CT Lung AI-powered lung CT analysis solution for lung cancer screening and pulmonary nodule detection, designed for hospitals, radiology departments, and large-scale lung cancer screening programs.
  • InferRead DR Chest AI-assisted digital chest X-ray interpretation software that detects and classifies thoracic abnormalities, including tuberculosis, targeting hospitals, TB screening programs, and government public-health initiatives.
  • InferRead CT Stroke AI triage software that analyzes non-contrast head CT scans to flag suspected intracerebral hemorrhage and large vessel occlusion, supporting emergency radiology and stroke centers in time-critical decisions.
  • InferRead CT Coronary AI software for coronary CT angiography that performs automatic coronary artery segmentation, plaque characterization, and stenosis assessment, intended for cardiology departments and advanced imaging centers.
  • InferRead CT Bone AI bone analysis software that automates bone age assessment and supports orthopedic CT interpretation for hospitals, pediatric imaging, and orthopedic departments.
  • InferRead CT Pneumonia AI software that detects, segments, and quantifies pneumonia-related opacities on chest CT, designed to support radiology departments during high-volume infectious disease surges such as COVID-19.
  • InferOperate Thorax Planning AI surgical planning software that performs automatic lung lesion segmentation and 3D anatomical reconstruction to support thoracic surgeons in pre-operative planning.
  • InferOperate Liver Planning AI software for liver surgical planning that provides automatic liver and lesion segmentation, vascular reconstruction, and volumetric analysis for hepatobiliary surgeons.
  • InferOperate Urology Planning AI surgical planning software that performs automatic kidney and prostate segmentation with 3D reconstruction, supporting urologists in pre-operative planning.
  • InferOperate Suite Unified surgical planning platform that consolidates InferOperate thoracic, liver, and urology planning modules into a single clinical workflow environment for surgical departments.
  • InferCare AI-enabled patient management software that organizes imaging findings, longitudinal records, and follow-up workflows for oncology and chronic disease management in hospital settings.
  • InferCare RECIST FDA-cleared AI software that performs automated tumor response assessment according to RECIST 1.1 criteria, supporting oncologists and radiology teams in follow-up imaging workflows.
  • InferScholar Medical imaging AI research platform that enables hospitals and research institutions to develop, validate, and operationalize custom deep learning models for clinical research projects.
  • InferMatrix Integrated AI application platform that hosts and orchestrates multiple Infervision imaging AI modules within a unified clinical workflow interface for hospitals and imaging centers.
  • InferAir Portable digital X-ray device with embedded AI for chest and tuberculosis screening, designed for mobile clinics, remote health programs, and resource-limited healthcare settings.

Quantifiable outcome

  • 93.1% station-specific sensitivity for detecting cancerous lymph nodes in chest CT scans
  • +6 more outcomes

Companies that use Infervision

Customer profile

Named customers12 records

Segments5 records

Ideal customer profiles3 records

Infervision technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability5 records

Feature13 records

Infervision partnerships and signals

Strategic signal

Partnerships

Twelve partnerships are on record, tiered core, major, strategic and minor.

  • MicrosoftcoreTechnology or Integration · 30 November 2025InferVision's AI models have been integrated into the Microsoft Precision Imaging Network (Microsoft + Nuance). Through cloud deployment via Azure, this partnership enables accelerated, standardized, and widely accessible intelligent imaging workflows for healthcare institutions worldwide. The integration leverages Microsoft's healthcare customer base and cloud infrastructure.
  • NVIDIAcoreTechnology or Integration · 30 November 2025InferVision leverages NVIDIA's advanced MONAI framework and TensorRT-accelerated inference to enhance AI development across screening, diagnosis, surgical planning, and oncology analysis. The MONAI framework has improved InferVision's R&D efficiency, while NVIDIA's DLI training supports advancement of large-model technologies.
  • Sanford HealthmajorStrategic or Co-development PartnerResearch collaboration with Sanford Health (largest rural nonprofit healthcare system in the US with 56 hospitals and nearly 300 clinics) for AI-powered cancer detection. Sanford Health researchers used Infervision's AI system combining RetinaNet detection algorithm with UNet segmentation model for detecting cancerous lymph nodes in chest CT scans, achieving 93.1% station-specific sensitivity.
  • SimonMedmajorStrategic or Co-development PartnerPartnership with SimonMed, one of the largest outpatient medical imaging providers in the US. Established in 2023, this partnership enables Infervision to access a large network of imaging centers for deployment of AI diagnostic solutions.
  • United Nations Development Programme (UNDP)majorChannel Partner/ Reseller/ DistributorPartnership with UNDP for TB screening programs in developing countries. UNDP and governments work together to deploy Infervision's AI solutions for tuberculosis screening in countries like Kyrgyzstan and Zimbabwe.
  • Global FundmajorChannel Partner/ Reseller/ DistributorPartnership with Global Fund for deployment of AI-powered TB screening in resource-limited settings. The Global Fund supports health programs in developing countries and has partnered with Infervision to deploy InferAir technology.
  • Harvard UniversitystrategicStrategic or Co-development PartnerMedical mission partnership with Harvard University for deploying InferAir (AI-powered ultra-portable X-ray) in remote Philippines islands. Harvard researchers collaborated with Partners in Health and Infervision for healthcare delivery to underserved populations.
  • Partners in HealthstrategicStrategic or Co-development PartnerPartnership with Partners in Health for medical missions deploying AI-powered healthcare solutions in remote areas. Combined effort with Harvard University and Infervision for remote island healthcare delivery.
  • University Hospital FrankfurtminorStrategic or Co-development PartnerClinical collaboration with University Hospital Frankfurt where Dr. Sayzana Kassahun uses InferOperate Thorax for thoracic surgery planning. The hospital serves as a reference site and provides clinical feedback for product development.
  • Hôpital Tenon (Tenon University Hospital Paris)minorStrategic or Co-development PartnerClinical collaboration with Hôpital Tenon in Paris where Dr. Harry Etienne uses InferOperate Thorax for minimally invasive thoracic surgery. The hospital serves as a reference site for surgical planning AI.
  • NHS (UK National Health Service)majorChannel Partner/ Reseller/ DistributorInfervision product selected into NHS procurement list in 2022, enabling deployment across UK National Health Service hospitals and healthcare facilities.
  • European Commission / UNOPSmajorChannel Partner/ Reseller/ DistributorProduct procured by the European Commission and included in medical devices ordering list under Global Drug Facility (GDF) hosted by United Nations Office for Project Services (UNOPS) in 2020. Enables deployment in European and international health programs.

Scale indicators9 records

Recent moves7 records

Expansion highlights6 records

Infervision competitors and assessment

Company assessment

Direct peers

  • DeepHealth (RadNet): DeepHealth, a RadNet subsidiary, provides AI-powered diagnostic and screening radiology solutions including lung, breast, and prostate imaging. It competes with Infervision's InferRead product line and benefits from RadNet's large outpatient imaging footprint, similar to Infervision's SimonMed partnership.
  • Qure.ai: Qure.ai develops deep learning algorithms for chest X-ray, CT lung nodule detection, head CT triage, and tuberculosis screening — closely matching Infervision's product portfolio. It is a direct competitor in both hospital radiology and government TB screening programs in emerging markets.
  • Lunit: Lunit is a Korea-based medical AI company with FDA-cleared chest X-ray and mammography AI products (Lunit INSIGHT). It competes with InferRead DR Chest and similar lung cancer screening use cases and has overlapping hospital and screening program customers.
  • Viz.ai: Viz.ai specializes in AI-powered stroke and cardiology triage, with FDA-cleared algorithms for large vessel occlusion detection and care coordination. It directly overlaps with Infervision's InferRead CT Stroke and CT Coronary products and competes for similar hospital radiology and neurovascular contracts.
  • Aidoc: Aidoc is a leading AI medical imaging company offering deep learning algorithms for triage and detection across CT and X-ray modalities (e.g., stroke, pulmonary embolism, intracranial hemorrhage). It competes directly with Infervision's InferRead suite in hospital AI workflows and shares similar enterprise sales motion and regulatory clearance strategy.
  • Annalise.ai: Annalise.ai provides comprehensive AI analysis across chest X-ray and CT, including 130+ findings detection. It competes directly with InferRead DR Chest and CT Lung in multi-finding chest imaging workflows and targets similar hospital radiology customers.

Emerging players

  • Nanox (Zebra Medical Vision): Nanox acquired Zebra Medical Vision, an AI medical imaging company with broad population-health imaging algorithms across CT and X-ray. It overlaps with Infervision's screening and diagnosis portfolio and competes in value-based care AI deployment models.

Broad incumbents

  • Philips (IntelliSpace AI): Philips is a global medical imaging incumbent with IntelliSpace AI, an imaging informatics platform offering Algorithm Marketplace integration with third-party AI including radiology AI. As a broad incumbent, it competes with Infervision by offering embedded AI within its installed PACS/imaging base.
  • Siemens Healthineers (AI-Rad Companion): Siemens Healthineers offers AI-Rad Companion, a radiology AI suite integrated into its imaging modalities and teamplay platform. As a major imaging equipment OEM, it competes with Infervision's InferRead and InferOperate by bundling AI into installed scanner bases.

Regional players

  • United Imaging Intelligence: United Imaging Intelligence is the AI subsidiary of United Imaging Healthcare, a major Chinese medical imaging equipment manufacturer. It offers AI-powered imaging analytics for CT, MR, and X-ray, serving similar hospital customers in China and competing with Infervision's domestic Chinese business.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

Infervision social profiles

Digital presence

Infervision compliance and trust

Trust signal

Compliance5 records

Infervision financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Infervision leadership team

Management profile

Number of profiles

Profiles4 records

Infervision funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors16 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Infervision M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Infervision

What does Infervision do?

Infervision develops and sells AI-powered medical imaging software that applies deep learning and computer vision to support screening, diagnosis, surgical planning, and patient management across CT, X-ray, MRI, and ultrasound modalities. The portfolio spans lung and chest screening, stroke triage, coronary analysis, bone age assessment, pneumonia detection, and a dedicated line of surgical planning and post-treatment follow-up tools sold primarily to hospitals, radiology departments, and public health programs.

Is Infervision a public or private company?

Infervision is a private company. It is classified as venture growth investor backed and is currently operating.

When was Infervision founded?

Infervision was founded in 2016. It employs 51 to 100 people.

Where is Infervision based?

Infervision is headquartered in Lyndhurst, United States, in the North America region.

How does Infervision make money?

One revenue line is on record: AI Medical Imaging Software Licenses.

Who are Infervision's main competitors?

Direct peers on record are DeepHealth (RadNet), Qure.ai, Lunit, Viz.ai, Aidoc and Annalise.ai. Nanox (Zebra Medical Vision) is listed as an emerging player. Broad incumbents are Philips (IntelliSpace AI) and Siemens Healthineers (AI-Rad Companion). United Imaging Intelligence is listed as a regional player.

Does Infervision have an API?

No public API is recorded for Infervision.

What industry is Infervision in?

Infervision's product category is AI Medical Imaging Software. Its primary akta.pro industry code is HLAHABAJ, Radiology AI, CAD & Advanced Visualization Software, with a secondary code of HDAAAEAH, Medical Imaging AI. Its NAICS code is 33451 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AcrofanMedical AI Ecosystem Innovation Forum and iMedLoop Global Medical Imaging Data Platform Launch Held in BeijingDiagens Technology officially launched the iMedLoop Global Medical Imaging Data Platform at the Medical AI Ecosystem Innovation Forum held in Beijing on July 4, 2026, with more than 100 representatives from government, industry, and academic sectors in attendance. The platform integrates the iMedImage® foundation model, iMedStudio intelligent annotation tool, and iMedMaaS model training platform, and already onboarded over 3,000 professional annotators with 28.95 million high-quality data records and more than 100 medical AI models deployed. More than 30 strategic cooperation agreements were signed during the event, including with Hangzhou Data Group, Legend Holdings, InferVision, and various hospitals and research institutions.ThemalaysianreserveMedical AI Ecosystem Innovation Forum and iMedLoop Global Medical Imaging Data Platform Launch Held in BeijingThe Medical AI Ecosystem Innovation Forum was held in Beijing on July 4, 2026, jointly organized by Liaowang Finance and Diagens Technology, bringing together over 100 representatives from government, industry, academia, and healthcare sectors. Diagens Technology officially launched the iMedLoop Global Medical Imaging Data Platform, which integrates its iMedImage® foundation model, iMedStudio intelligent annotation tool, and iMedMaaS model training platform, onboarding 3,000+ annotators, processing 28.95 million data records, and deploying 100+ medical AI models. More than 30 strategic cooperation agreements were signed at the event with hospitals, research institutions, and technology companies including InferVision, Hangzhou Data Group, and Legend Holdings to build a collaborative medical AI innovation ecosystem under China's Healthy China initiative.tirto.idMedical AI Ecosystem Innovation Forum and iMedLoop Global Medical Imaging Data Platform Launch Held in BeijingOn July 4, 2026, Diagens Technology officially launched the iMedLoop Global Medical Imaging Data Platform at the Medical AI Ecosystem Innovation Forum in Beijing, jointly organized with Liaowang Finance, positioning it as a closed-loop ecosystem for medical data annotation, vertical AI model training, and deployment. The platform, which integrates Diagens' iMedImage® foundation model and iMedStudio annotation tool, has onboarded over 3,000 professional annotators, accumulated 28.95 million high-quality data records, and deployed more than 100 medical AI models in collaboration with 87 leading hospitals. More than 30 strategic cooperation agreements were signed during the forum with institutions including Hangzhou Data Group, Legend Holdings, InferVision, and Zhejiang Cancer Hospital to advance China's participation in the global medical AI ecosystem.openPR.comAI-Enabled Medical Imaging Solutions Market to Reach $33.76B by 2033 North America Leads with 38% Share Key Players: Aidoc, Infervision, Qure.ai, Brainomix, DeepTek, Rad AIThe global AI-enabled medical imaging solutions market reached $10.63 billion in 2024 and is projected to grow to $33.76 billion by 2033, reflecting a CAGR of 13.8% during the forecast period. North America leads the market with approximately 38% share, driven by advanced healthcare infrastructure, early AI adoption in radiology, and strong presence of key players such as GE HealthCare, Siemens Healthineers, Philips Healthcare, and Canon Medical Systems, alongside AI-native companies Aidoc, Infervision, Qure.ai, and Brainomix. Key market drivers include the rising aging population requiring frequent medical imaging, increasing prevalence of chronic diseases, and over 500 FDA-cleared AI algorithms with 75% focused on radiology, while data privacy and security concerns present significant restraints to adoption.PR NewswireInfervision Partnership with ConcertAI's TeraRecon brings their Lung CT.AI to Eureka Clinical AIInfervision's Lung CT.AI algorithm was added to TeraRecon's Eureka Clinical AI platform, enabling automated lung nodule detection in CT scans. Infervision's AI products are used by over 900 healthcare providers in nearly 20 countries. The integration aims to improve diagnostic accuracy and efficiency for lung cancer screening.BioWorldInfervision receives nod for AI-powered CT reader in ChinaInfervision Medical Technology received NMPA approval for its AI-powered CT reader Inferread CT Stroke. This is the company's first class III approval in the cerebro-cardiovascular field, indicating a high-risk medical device.Sanford HealthDoctors teach AI to help spot cancer in image scansThree Sanford Health radiologists in Bismarck, North Dakota are collaborating with InferVision US Inc., a medical imaging AI technology company, to develop an AI tool that identifies cancer in CT scan images. The radiologists annotate de-identified CT scans by circling potentially cancerous areas, which are used to train the AI model—currently in its third version—with the goal of improving cancer detection accuracy as a "second pair of eyes" for radiologists. The technology, which uses federated learning to keep patient data secure on Sanford Health's network, is being expanded beyond chest scans to other body areas and has potential to benefit patients beyond Sanford Health's own system.BloombergGoldman Sachs-Backed InferVision Picks Banks for Hong Kong IPOInferVision, a medical AI firm, is planning a Hong Kong IPO with banks CSC Financial, Goldman Sachs, and UBS, potentially raising about $300 million. Goldman Sachs Asset Management and Qiming Venture Partners are among its backers, and the share sale could begin this year.PR NewswireInferVision AI помогает ЕК контролировать распространение вариантов COVID-19InferVision AI was selected by the European Commission to expand AI-powered COVID-19 variant monitoring across the European Union. The company's AI tools, which analyze CT chest scans to detect signs of viral pneumonia and track disease progression, have been used by hospitals in Belgium, France, Estonia, Italy, Portugal, Romania, Spain, Sweden, and the Netherlands since April 2020. The European Commission cited InferVision's technical excellence, rapid deployment capability, and installation feasibility as the three criteria that qualified the company for the expanded contract.PR NewswireUmelá inteligencia InferVision pomáha Európskej komisii pri monitorovaní variantov ochorenia COVID-19InferVision AI was selected by the European Commission to monitor COVID-19 variants across the European Union, building on the company's existing AI tools that have been used since April 2020 to improve COVID-19 detection and patient treatment efficiency. Hospitals in Belgium, Estonia, France, Italy, Portugal, Romania, Spain, Sweden, and the Netherlands report significant benefits from the technology, which analyzes CT chest scans to identify patterns of viral pneumonia. The European Commission selected InferVision based on three criteria—technical excellence, rapid deployment capability, and feasibility of hospital installation plans—and expects the extended contract to provide further evidence of AI benefits in healthcare.